United Therapeutics reported 432M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Amarin USD 45.66M 5.3M Mar/2025
Ardelyx USD 21.68M 5.68M Jun/2025
Baxter International USD 963M 5M Mar/2025
Bayer EUR 6.04B 549M Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
GlaxoSmithKline 14.82B 329M Jun/2025
Halozyme Therapeutics USD 18.69M 1.38M Jun/2025
Insmed USD 78.35M 16.95M Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
J&J USD 9.54B 766M Mar/2025
Moderna USD 175M 51M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Teva Pharmaceutical Industries USD 2.5B 208M Jun/2025
United Therapeutics 432M 426M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025